Saeko Uchida

577 total citations
17 papers, 440 citations indexed

About

Saeko Uchida is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Saeko Uchida has authored 17 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Saeko Uchida's work include Diabetes Treatment and Management (7 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pancreatic function and diabetes (3 papers). Saeko Uchida is often cited by papers focused on Diabetes Treatment and Management (7 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pancreatic function and diabetes (3 papers). Saeko Uchida collaborates with scholars based in Japan. Saeko Uchida's co-authors include Motoko Ohata, Keizo Arihara, Koichiro Shiokawa, Mari Aoki, Shigeo Morimoto, Hiroshi Hara, Teisuke Takahashi, Yukihiro Chino, Hiroyuki Kakinuma and Masayuki Arai and has published in prestigious journals such as Food Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Saeko Uchida

16 papers receiving 428 citations

Peers

Countries citing papers authored by Saeko Uchida

Since Specialization

Citations

This map shows the geographic impact of Saeko Uchida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saeko Uchida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saeko Uchida more than expected).

Fields of papers citing papers by Saeko Uchida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saeko Uchida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saeko Uchida. The network helps show where Saeko Uchida may publish in the future.

Co-authorship network of co-authors of Saeko Uchida

This figure shows the co-authorship network connecting the top 25 collaborators of Saeko Uchida. A scholar is included among the top collaborators of Saeko Uchida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saeko Uchida. Saeko Uchida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis 2025 ·Rheumatology and Therapy ·Yoshiya Tanaka, (unknown), (unknown), (unknown), (unknown), Saeko Uchida, Tsutomu Takeuchi	0
2	Effects of SGLT2 inhibitors on the onset of esophageal varices and extrahepatic cancer in type 2 diabetic patients with suspected MASLD: a nationwide database study in Japan 2024 ·Journal of Gastroenterology ·Takumi Kawaguchi, Yoshiyuki Fujishima, (unknown), (unknown), Yuri Sato, Saeko Uchida, (unknown)	15
3	Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials 2024 ·Journal of Gastroenterology ·Takumi Kawaguchi, Kenta Murotani, (unknown), (unknown), Hironori Yamaguchi, (unknown), (unknown), Yutaka Seino, Saeko Uchida	4
4	Population Pharmacokinetics of Ozoralizumab in Patients with Rheumatoid Arthritis 2023 ·The Journal of Clinical Pharmacology ·Tsutomu Takeuchi, Yukihiro Chino, Yoko Mano, (unknown), Yuri Sato, Saeko Uchida, Yoshiya Tanaka	2
5	Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials 2023 ·Arthritis Research & Therapy ·Tsutomu Takeuchi, Yukihiro Chino, (unknown), (unknown), (unknown), Yoko Mano, Yuri Sato, Saeko Uchida, Yoshiya Tanaka	19
6	TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Sota Kato, (unknown), Hiroki Takano, (unknown), (unknown), (unknown), (unknown), Saeko Uchida, Koji Yamamoto	17
7	SGL5213, a novel and potent intestinal SGLT1 inhibitor, suppresses intestinal glucose absorption and enhances plasma GLP-1 and GLP-2 secretion in rats 2019 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), Koji Kato, (unknown), (unknown), (unknown), Saeko Uchida, Koji Yamamoto	8
8	TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlation 2018 ·European Journal of Pharmacology ·Sota Kato, (unknown), Hiroki Takano, (unknown), (unknown), (unknown), Saeko Uchida, Teisuke Takahashi, Koji Yamamoto	5
9	Antioxidant activity of fermented meat sauce and isolation of an associated antioxidant peptide 2015 ·Food Chemistry ·Motoko Ohata, Saeko Uchida, (unknown), Keizo Arihara	67
10	In vitro characterization of luseogliflozin, a potent and competitive sodium glucose co-transporter 2 inhibitor: Inhibition kinetics and binding studies 2015 ·Journal of Pharmacological Sciences ·Saeko Uchida, Akiko Mitani, (unknown), Teisuke Takahashi, Koji Yamamoto	14
11	A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans 2014 ·Drug Metabolism and Disposition ·(unknown), Yasuhiro Nakai, (unknown), Saeko Uchida, Teisuke Takahashi, (unknown), (unknown), Soichi Sakai, Yoshishige Samukawa, Junichi Yamaguchi	5
12	(1S)-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol (TS-071) is a Potent, Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for Type 2 Diabetes Treatment 2010 ·Journal of Medicinal Chemistry ·Hiroyuki Kakinuma, (unknown), (unknown), Masayuki Arai, (unknown), Yoshiki Fukasawa, Izumi Iida, (unknown), Hiroyuki Takeuchi, Yukihiro Chino, (unknown), (unknown), (unknown), Daisuke Yamamoto, Noriyuki Miyata, Teisuke Takahashi, Saeko Uchida, Koji Yamamoto	127
13	Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice 2009 ·Life Sciences ·Xibao Liu, Norio Harada, Shunsuke Yamane, (unknown), Saeko Uchida, Akihiro Hamasaki, Eri Mukai, Kentaro Toyoda, Chizumi Yamada, Yuichiro Yamada, Yutaka Seino, Nobuya Inagaki	11
14	Xantholipin, a novel inhibitor of HSP47 gene expression produced by Streptomyces sp. 2003 ·Tetrahedron Letters ·(unknown), Yiwen Chu, (unknown), (unknown), Haruaki Yamamoto, (unknown), Yasumitsu Tomishima, Saeko Uchida, (unknown), (unknown), Takayuki Seki, Koji Yamamoto, Shigeru Murakami, Akira Kawashima	31
15	Molecular cloning and functional expression analysis of a cDNA for human hepassocin, a liver-specific protein with hepatocyte mitogenic activity 2001 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Hiroshi Hara, (unknown), Saeko Uchida, (unknown), Mari Aoki, (unknown), Shigeo Morimoto, Koichiro Shiokawa	57
16	Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration 2000 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Hiroshi Hara, Saeko Uchida, (unknown), Mari Aoki, (unknown), (unknown), Shigeo Morimoto, Hiroshi Fukamachi, Koichiro Shiokawa, Kazunori Hanada	48
17	Up-regulation of low density lipoprotein receptor by a novel isobenzofranone derivative, MD-700 1999 ·Atherosclerosis ·Shigeru Murakami, (unknown), Saeko Uchida, (unknown), (unknown), (unknown), Masakazu Sato, (unknown), Hiroshi Hara, Kazuyuki Tomisawa, (unknown), (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact